S&P 500   3,136.06 (+0.00%)
DOW   27,909.87 (+0.00%)
QQQ   204.22 (+0.07%)
AAPL   269.06 (+0.80%)
FB   200.58 (-0.38%)
MSFT   151.35 (-0.01%)
GOOGL   1,344.13 (+0.08%)
CGC   20.06 (-5.78%)
NVDA   214.65 (+1.17%)
BABA   201.44 (+1.36%)
GE   11.01 (+0.18%)
TSLA   348.98 (+2.78%)
T   38.08 (+0.11%)
AMD   39.52 (+1.52%)
ACB   2.51 (-4.19%)
F   9.08 (+0.67%)
GILD   66.99 (+0.09%)
DIS   146.27 (+0.03%)
S&P 500   3,136.06 (+0.00%)
DOW   27,909.87 (+0.00%)
QQQ   204.22 (+0.07%)
AAPL   269.06 (+0.80%)
FB   200.58 (-0.38%)
MSFT   151.35 (-0.01%)
GOOGL   1,344.13 (+0.08%)
CGC   20.06 (-5.78%)
NVDA   214.65 (+1.17%)
BABA   201.44 (+1.36%)
GE   11.01 (+0.18%)
TSLA   348.98 (+2.78%)
T   38.08 (+0.11%)
AMD   39.52 (+1.52%)
ACB   2.51 (-4.19%)
F   9.08 (+0.67%)
GILD   66.99 (+0.09%)
DIS   146.27 (+0.03%)
S&P 500   3,136.06 (+0.00%)
DOW   27,909.87 (+0.00%)
QQQ   204.22 (+0.07%)
AAPL   269.06 (+0.80%)
FB   200.58 (-0.38%)
MSFT   151.35 (-0.01%)
GOOGL   1,344.13 (+0.08%)
CGC   20.06 (-5.78%)
NVDA   214.65 (+1.17%)
BABA   201.44 (+1.36%)
GE   11.01 (+0.18%)
TSLA   348.98 (+2.78%)
T   38.08 (+0.11%)
AMD   39.52 (+1.52%)
ACB   2.51 (-4.19%)
F   9.08 (+0.67%)
GILD   66.99 (+0.09%)
DIS   146.27 (+0.03%)
S&P 500   3,136.06 (+0.00%)
DOW   27,909.87 (+0.00%)
QQQ   204.22 (+0.07%)
AAPL   269.06 (+0.80%)
FB   200.58 (-0.38%)
MSFT   151.35 (-0.01%)
GOOGL   1,344.13 (+0.08%)
CGC   20.06 (-5.78%)
NVDA   214.65 (+1.17%)
BABA   201.44 (+1.36%)
GE   11.01 (+0.18%)
TSLA   348.98 (+2.78%)
T   38.08 (+0.11%)
AMD   39.52 (+1.52%)
ACB   2.51 (-4.19%)
F   9.08 (+0.67%)
GILD   66.99 (+0.09%)
DIS   146.27 (+0.03%)
Log in

Dr.Reddy's Laboratories Price Target & Analyst Ratings (NYSE:RDY)

$40.99
+0.49 (+1.21 %)
(As of 12/10/2019 02:03 PM ET)
Today's Range
$40.56
Now: $40.99
$41.13
50-Day Range
$38.15
MA: $39.77
$41.92
52-Week Range
$34.67
Now: $40.99
$42.82
Volume3,871 shs
Average Volume163,969 shs
Market Capitalization$6.79 billion
P/E Ratio24.99
Dividend Yield0.65%
Beta0.2

Analyst Ratings

Dr.Reddy's Laboratories (NYSE:RDY) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Dr.Reddy's Laboratories in the last 12 months. Their average twelve-month price target is $39.00, suggesting that the stock has a possible downside of 4.85%. The high price target for RDY is $39.00 and the low price target for RDY is $39.00. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.252.252.292.00
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $39.00$39.00$39.00$39.00
Price Target Upside: 4.85% downside2.11% downside7.14% upside2.90% upside

Dr.Reddy's Laboratories (NYSE:RDY) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Dr.Reddy's Laboratories (NYSE:RDY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/4/2019Bank of AmericaDowngradeBuy ➝ NeutralMedium
9/4/2019Credit Suisse GroupUpgradeUnderperform ➝ OutperformLow
7/1/2019MacquarieUpgradeNeutral ➝ OutperformLow
6/20/2019Deutsche BankInitiated CoverageHold ➝ HoldLow
6/11/2019BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$39.00Low
5/20/2019Morgan StanleyDowngradeOverweight ➝ Equal WeightHigh
2/4/2019CL KingUpgradeNeutral ➝ BuyLow
1/17/2019CitigroupDowngradeNeutral ➝ SellLow
(Data available from 12/10/2017 forward)
This page was last updated on 12/10/2019 by MarketBeat.com Staff

Featured Article: Hold Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel